Thymic Carcinoma, also known as malignant thymoma, is related to lymphoepithelioma-like thymic carcinoma and thymus adenocarcinoma. An important gene associated with Thymic Carcinoma is KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase), and among its related pathways/superpathways are Cytoskeletal Signaling and Hippo-Merlin signaling dysregulation. The drugs Pembrolizumab and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include thymus and thyroid, and related phenotypes are mediastinal lymphadenopathy and neoplasm of the thymus